Insider · CIK 0001608601

Bowden Christopher

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001608601

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.5K sh	—	—	19,475
2025-06-09	BCAXBicara Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.7K sh	—	—	23,746
2022-06-22	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-22	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+40K sh	—	—	44,167
2021-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,885 sh	$39.76	+$74.9K	17,372
2021-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+46.6K sh	$50.40	+$2.35M	63,980
2021-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−46.6K sh	—	—	992
2021-06-18	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−48.5K sh	$60.11	−$2.91M	15,487
2021-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,885 sh	—	—	0
2021-06-17	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,502 sh	—	—	1,885
2021-06-17	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,502 sh	$39.76	+$99.5K	17,989
2021-06-17	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−2,502 sh	$60.02	−$150K	15,487
2021-06-10	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+20.9K sh	$39.76	+$829K	36,340
2021-06-10	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−20.9K sh	$60.06	−$1.25M	15,487
2021-06-10	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−20.9K sh	—	—	4,387
2021-06-09	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,149 sh	—	—	25,240
2021-06-09	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,149 sh	$39.76	+$284K	22,636
2021-06-09	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−7,149 sh	$60.16	−$430K	15,487
2021-06-08	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,675 sh	—	—	32,389
2021-06-08	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−6,675 sh	$60.07	−$401K	15,487
2021-06-08	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,675 sh	$39.76	+$265K	22,162
2021-06-07	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,268 sh	$39.76	+$170K	19,755
2021-06-07	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,268 sh	—	—	39,064
2021-06-07	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−4,268 sh	$60.04	−$256K	15,487
2021-04-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.5K sh	$35.16	+$440K	28,000
2021-04-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,888 sh	—	—	43,332
2021-04-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.5K sh	—	—	0
2021-04-20	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−14.4K sh	$55.11	−$794K	15,487
2021-04-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,888 sh	$39.76	+$75.1K	29,888
2021-04-19	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−3,210 sh	$55.16	−$177K	15,487
2021-04-19	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,210 sh	$35.16	+$113K	18,697
2021-04-19	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,210 sh	—	—	12,513
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.3K sh	—	—	31,250
2021-03-04	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+4,167 sh	—	—	4,167
2021-02-24	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−986 sh	—	—	15,410
2021-02-22	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,334 sh	—	—	16,396
2021-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,334 sh	—	—	3,333
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,750 sh	—	—	15,131
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,750 sh	—	—	0
2021-02-16	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,069 sh	—	—	13,062
2021-02-14	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	—	—	12,381
2021-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	8,000
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Chief Medical Officer	AAward	+44K sh	—	—	44,000
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Medical Officer	AAward	+11K sh	—	—	11,000
2020-05-21	VRDNViridian Therapeutics, Inc.\DE · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2020-05-20	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Medical Officer	SSale	−3,583 sh	$50.01	−$179K	8,306
2020-05-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,583 sh	$35.16	+$126K	11,889
2020-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,583 sh	—	—	15,723
2020-04-14	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,368 sh	$40.64	−$96.2K	8,230
2020-04-13	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,280 sh	—	—	10,561

Recent filings

Accepted (ET)
Jun 104
Bowden Christopher0001628280-26-042255
SEC(opens sec.gov)
Jun 104
Bowden Christopher0002023658-25-000073
SEC(opens sec.gov)
Jun 244
Bowden Christopher0000899243-22-023978
SEC(opens sec.gov)
Jun 224
Bowden Christopher0001439222-21-000059
SEC(opens sec.gov)
Jun 214
Bowden Christopher0001439222-21-000058
SEC(opens sec.gov)
Jun 114
Bowden Christopher0001439222-21-000057
SEC(opens sec.gov)
Jun 94
Bowden Christopher0001439222-21-000056
SEC(opens sec.gov)

Companies

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116